CY1110464T1 - Παραγωγα πυραζολοπυριδινης ως αναστολεις του βητα-αδρενεργικου υποδοχεα της κινασης1 - Google Patents
Παραγωγα πυραζολοπυριδινης ως αναστολεις του βητα-αδρενεργικου υποδοχεα της κινασης1Info
- Publication number
- CY1110464T1 CY1110464T1 CY20091100501T CY091100501T CY1110464T1 CY 1110464 T1 CY1110464 T1 CY 1110464T1 CY 20091100501 T CY20091100501 T CY 20091100501T CY 091100501 T CY091100501 T CY 091100501T CY 1110464 T1 CY1110464 T1 CY 1110464T1
- Authority
- CY
- Cyprus
- Prior art keywords
- beta
- adenergic
- pyrazolopyridine
- producers
- cells
- Prior art date
Links
- AMFYRKOUWBAGHV-UHFFFAOYSA-N 1h-pyrazolo[4,3-b]pyridine Chemical compound C1=CN=C2C=NNC2=C1 AMFYRKOUWBAGHV-UHFFFAOYSA-N 0.000 title 1
- 241000711549 Hepacivirus C Species 0.000 abstract 2
- 206010007558 Cardiac failure chronic Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000026251 Opioid-Related disease Diseases 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000031225 myocardial ischemia Diseases 0.000 abstract 1
- 201000005040 opiate dependence Diseases 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000005229 pyrazolopyridines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Η εφεύρεση αναφέρεται στα 6-αμιδο υποκατεστημένα παράγωγα πυραζολοπυριδίνης του χημικού τύπου (I) τα οποία είναι χρήσιμα ως αναστολείς του βητα- αδρενεργικού υποδοχέα κινάσης 1 (βARK-1), σε σκευάσματα που περιέχουν αυτού του είδους τις ενώσεις και στην χρήση τους για την θεραπεία και τη πρόληψη της χρόνιας καρδιακής ανεπάρκειας, της υπέρτασης, της ισχαιμίας του μυοκαρδίου και των μολύνσεων από τον ιό της ηπατίτιδας C (HCV), και για την πρόληψη του εθισμού στο όπιο.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05013774 | 2005-06-27 | ||
| EP06754324A EP1899333B1 (en) | 2005-06-27 | 2006-06-13 | Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110464T1 true CY1110464T1 (el) | 2015-04-29 |
Family
ID=35395578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100501T CY1110464T1 (el) | 2005-06-27 | 2009-05-11 | Παραγωγα πυραζολοπυριδινης ως αναστολεις του βητα-αδρενεργικου υποδοχεα της κινασης1 |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7910602B2 (el) |
| EP (1) | EP1899333B1 (el) |
| JP (1) | JP5010594B2 (el) |
| KR (1) | KR20080020638A (el) |
| CN (1) | CN101208340B (el) |
| AR (1) | AR054514A1 (el) |
| AT (1) | ATE423118T1 (el) |
| AU (1) | AU2006264044A1 (el) |
| BR (1) | BRPI0612320A2 (el) |
| CA (1) | CA2611296A1 (el) |
| CY (1) | CY1110464T1 (el) |
| DE (1) | DE602006005242D1 (el) |
| DK (1) | DK1899333T3 (el) |
| ES (1) | ES2322197T3 (el) |
| HR (1) | HRP20090244T2 (el) |
| IL (1) | IL188381A0 (el) |
| MA (1) | MA29498B1 (el) |
| MX (1) | MX2007015829A (el) |
| MY (1) | MY139016A (el) |
| NO (1) | NO20080392L (el) |
| NZ (1) | NZ564757A (el) |
| PL (1) | PL1899333T3 (el) |
| PT (1) | PT1899333E (el) |
| RS (1) | RS50821B (el) |
| RU (1) | RU2415855C2 (el) |
| SI (1) | SI1899333T1 (el) |
| TW (1) | TW200800982A (el) |
| UY (1) | UY29632A1 (el) |
| WO (1) | WO2007000241A1 (el) |
| ZA (1) | ZA200709853B (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200815438A (en) | 2006-06-13 | 2008-04-01 | Bayer Schering Pharma Ag | Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| EP2253618A1 (en) * | 2008-02-27 | 2010-11-24 | Takeda Pharmaceutical Company Limited | Compound having 6-membered aromatic ring |
| US9321787B2 (en) * | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| CA2905242C (en) | 2013-03-15 | 2016-11-29 | Pfizer Inc. | Indole compounds that activate ampk |
| GB201410815D0 (en) * | 2014-06-17 | 2014-07-30 | Ucb Biopharma Sprl And Katholieke Universiteit Leuven | Therapeutic agents |
| KR20210080462A (ko) | 2018-10-24 | 2021-06-30 | 브리스톨-마이어스 스큅 컴퍼니 | 치환된 인돌 이량체 화합물 |
| CN112955450A (zh) * | 2018-10-24 | 2021-06-11 | 百时美施贵宝公司 | 经取代的吲哚和吲唑化合物 |
| WO2020227484A1 (en) | 2019-05-09 | 2020-11-12 | Bristol-Myers Squibb Company | Substituted benzimidazolone compounds |
| WO2021067326A1 (en) | 2019-10-01 | 2021-04-08 | Bristol-Myers Squibb Company | Substituted bicyclic heteroaryl compounds |
| EP4038059B1 (en) | 2019-10-04 | 2023-09-20 | Bristol-Myers Squibb Company | Substituted carbazole compounds |
| WO2024137671A1 (en) * | 2022-12-20 | 2024-06-27 | Exelixis, Inc. | Compounds that inhibit pkmyt1 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL181895B1 (pl) * | 1994-06-16 | 2001-10-31 | Pfizer | Nowe pirazolo-i pirolopirydyny _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ PL PL PL PL |
| ATE355841T1 (de) * | 1997-12-13 | 2007-03-15 | Bristol Myers Squibb Co | Verwendung von pyrazolo ( 3,4-b) pyridin als cyclin-abhängige kinase hemmer |
| JP2002020386A (ja) * | 2000-07-07 | 2002-01-23 | Ono Pharmaceut Co Ltd | ピラゾロピリジン誘導体 |
| WO2003068773A1 (en) * | 2002-02-12 | 2003-08-21 | Glaxo Group Limited | Pyrazolopyridine derivatives |
| EA200500322A1 (ru) * | 2002-08-07 | 2005-08-25 | Мицубиси Фарма Корпорейшн | Соединения дигидропиразолопиридина |
| CL2004000398A1 (es) * | 2003-02-27 | 2005-03-18 | Uriach Y Compania S A J | Compuestos derivados de pirazolopiridinas, sus sales; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar enfermedades mediadas por quinasas p38, en especial por citocinas, tnf-alfa, il-1, il-6 y/o il-8, tales como enfermedad |
-
2006
- 2006-06-13 EP EP06754324A patent/EP1899333B1/en active Active
- 2006-06-13 MX MX2007015829A patent/MX2007015829A/es active IP Right Grant
- 2006-06-13 CN CN200680023397XA patent/CN101208340B/zh not_active Expired - Fee Related
- 2006-06-13 BR BRPI0612320-1A patent/BRPI0612320A2/pt not_active IP Right Cessation
- 2006-06-13 WO PCT/EP2006/005649 patent/WO2007000241A1/en not_active Ceased
- 2006-06-13 KR KR1020077030289A patent/KR20080020638A/ko not_active Withdrawn
- 2006-06-13 PL PL06754324T patent/PL1899333T3/pl unknown
- 2006-06-13 RS RSP-2009/0165A patent/RS50821B/sr unknown
- 2006-06-13 AT AT06754324T patent/ATE423118T1/de not_active IP Right Cessation
- 2006-06-13 NZ NZ564757A patent/NZ564757A/en not_active IP Right Cessation
- 2006-06-13 SI SI200630284T patent/SI1899333T1/sl unknown
- 2006-06-13 JP JP2008518660A patent/JP5010594B2/ja not_active Expired - Fee Related
- 2006-06-13 DK DK06754324T patent/DK1899333T3/da active
- 2006-06-13 CA CA002611296A patent/CA2611296A1/en not_active Abandoned
- 2006-06-13 HR HR20090244T patent/HRP20090244T2/xx unknown
- 2006-06-13 RU RU2008102970/04A patent/RU2415855C2/ru not_active IP Right Cessation
- 2006-06-13 AU AU2006264044A patent/AU2006264044A1/en not_active Abandoned
- 2006-06-13 PT PT06754324T patent/PT1899333E/pt unknown
- 2006-06-13 ES ES06754324T patent/ES2322197T3/es active Active
- 2006-06-13 DE DE602006005242T patent/DE602006005242D1/de active Active
- 2006-06-23 TW TW095122584A patent/TW200800982A/zh unknown
- 2006-06-23 AR ARP060102721A patent/AR054514A1/es not_active Application Discontinuation
- 2006-06-26 MY MYPI20063009A patent/MY139016A/en unknown
- 2006-06-27 UY UY29632A patent/UY29632A1/es not_active Application Discontinuation
-
2007
- 2007-11-15 ZA ZA200709853A patent/ZA200709853B/xx unknown
- 2007-11-30 MA MA30441A patent/MA29498B1/fr unknown
- 2007-12-20 US US11/961,282 patent/US7910602B2/en not_active Expired - Fee Related
- 2007-12-24 IL IL188381A patent/IL188381A0/en unknown
-
2008
- 2008-01-21 NO NO20080392A patent/NO20080392L/no not_active Application Discontinuation
-
2009
- 2009-05-11 CY CY20091100501T patent/CY1110464T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110464T1 (el) | Παραγωγα πυραζολοπυριδινης ως αναστολεις του βητα-αδρενεργικου υποδοχεα της κινασης1 | |
| CY1119669T1 (el) | Παραγωγα 1-φαινυλ-2-πυριδινυλ-αλκυλ-αλκοολων ως αναστολεις φωσφοδιεστερασης | |
| CY1113560T1 (el) | Αζαϊνδολια χρησιμα ως αναστολεις των jak και αλλων πρωτεϊνικων κινασων | |
| CY1120994T1 (el) | Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων | |
| CY1115925T1 (el) | Παραγωγα πυριδαζινονης | |
| CY1121021T1 (el) | Ιμιδαζοτριαζινες και ιμιδαζοπυριμιδινες ως αναστολεις κινασης | |
| CY1113617T1 (el) | Νεα παραγωγα φαινυλαμινοπυριμιδινης ως αναστολεις της κινασης bcr-abl | |
| CY1113757T1 (el) | Παραγωγα πιπεριδινης και πιπεραζινης για τη θεραπεια ογκων | |
| CY1118717T1 (el) | Αναστολεις c-fms κινασης | |
| LU93078I2 (fr) | Combimetinib, éventuellement sous toute forme protégée par le brevet de base, y compris les sels et solvates pharmaceutiquement acceptables, en particulier hémifumarate de cobimetinib | |
| NO20075616L (no) | Tripeptider som hepatitt C virus inhibitorer | |
| EA200900184A1 (ru) | 4-амино-4-оксобутаноиловые пептиды как ингибиторы вирусной репликации | |
| EA200901241A1 (ru) | Соединения для лечения гепатита с | |
| CY1115898T1 (el) | Ενωσεις και συνθεσεις ως αναστολεις των πρωτεϊνικων κινασων | |
| NO20076502L (no) | Pyrrolopyridiner nyttige som inhibitorer av proteinkinase | |
| EA200900676A1 (ru) | Ингибиторы вируса гепатита с | |
| CY1113443T1 (el) | Παραγωγα πυριδαζινονης | |
| NO20091845L (no) | Macrocykliske peptider som hepatitt C virus-inhibitorer | |
| BRPI0606524A2 (pt) | derivados de indol para o tratamento de infecções virais | |
| BRPI0605921B8 (pt) | compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas | |
| ECSP055640A (es) | Composiciones de pirazol útiles como inhibidores de gsk-3 | |
| NO20073105L (no) | Pyridazinonforbindelser | |
| EA200800371A1 (ru) | Ингибиторы ns3 протеазы вгс | |
| CY1112019T1 (el) | Αγωνιστες υποδοχεων νιασινης, συνθεσεις που περιεχουν τετοιες ενωσεις και μεθοδοι θεραπειας | |
| DK2203430T3 (da) | N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV) |